ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

NCI Begins TAILORx Study.

May 26, 2006

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Becker, Brown Testify On Biomedical Funding, Manpower Needs

March 23, 1990

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010